Full Name | Sean E Nork |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 32 Years |
Location | 325 9th Ave, Seattle, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013059070 | NPI | - | NPPES |
8227068 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207XX0801X | Orthopaedic Surgery - Orthopaedic Trauma | MD00034896 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Harborview Medical Center | Seattle, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
The Association Of University Physicians | 0446162697 | 3009 |
News Archive
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
Researchers in the United States analyzed the non-structural protein 2 (Nsp2) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in order to better understand its function and to guide future drug discovery. The research paper is currently available on bioRxiv* preprint server.
News-Medical speaks to Professor Robert Bragg about disinfectants and how they could be helping bacteria to become resistant.
New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana.
Surgeons and transplant centers nationwide increasingly have rejected hearts donated for transplantation despite a growing need for them, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
Entity Name | The Association Of University Physicians |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
Researchers in the United States analyzed the non-structural protein 2 (Nsp2) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in order to better understand its function and to guide future drug discovery. The research paper is currently available on bioRxiv* preprint server.
News-Medical speaks to Professor Robert Bragg about disinfectants and how they could be helping bacteria to become resistant.
New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana.
Surgeons and transplant centers nationwide increasingly have rejected hearts donated for transplantation despite a growing need for them, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Sean E Nork, MD Po Box 50095, Seattle, WA 98145-5095 Ph: (206) 543-6420 | Sean E Nork, MD 325 9th Ave, Seattle, WA 98104 Ph: (206) 731-3462 |
News Archive
Monarch Medical Technologies, the pioneer and leader in mitigating risk associated with drugs and processes of concern in hospitalized patients, today announced the U.S. Food and Drug Administration clearance of its new glucose management solution, EndoTool IV.
Researchers in the United States analyzed the non-structural protein 2 (Nsp2) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in order to better understand its function and to guide future drug discovery. The research paper is currently available on bioRxiv* preprint server.
News-Medical speaks to Professor Robert Bragg about disinfectants and how they could be helping bacteria to become resistant.
New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana.
Surgeons and transplant centers nationwide increasingly have rejected hearts donated for transplantation despite a growing need for them, according to a new study by researchers at the Stanford University School of Medicine.
› Verified 9 days ago
Daniel G Schwartz, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Broadway Ste 600, Seattle, WA 98122 Phone: 206-386-6171 Fax: 206-860-6634 | |
Karina Marie Katchko, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 325 9th Ave, Seattle, WA 98104 Phone: 206-520-5000 | |
Mr. Bahman Sahranavard Sr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Sean D Toomey, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Broadway, Seattle, WA 98122 Phone: 206-386-2600 Fax: 206-622-1644 | |
Dr. Wayne M Weil, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2409 N 45th St, Seattle, WA 98103 Phone: 206-633-8100 Fax: 206-633-6107 | |
Robert Paul Dunbar Jr., Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: Harborview Medical Center, 325 9th Ave, Seattle, WA 98104 Phone: 206-731-3462 | |
Christopher P Cannon, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 601 Broadway Ste 600, Seattle, WA 98122 Phone: 206-386-6171 Fax: 206-860-6634 |